{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:36:38Z","timestamp":1784860598758,"version":"3.55.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82370054"],"award-info":[{"award-number":["82370054"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82070049"],"award-info":[{"award-number":["82070049"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2024JJ6560"],"award-info":[{"award-number":["2024JJ6560"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There is a lack of research on the impact of hyperglycemia on the prognosis of patients with both chronic obstructive pulmonary disease (COPD) and coronary heart disease (CHD). This study aims to investigate the effect of hyperglycemia on long-term acute exacerbation frequency and mortality rates in COPD patients with CHD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This real-world and prospective study recruited inpatients with COPD from the second Xiangya Hospital of Central South University, in China in December 2016, with follow-up until March 2023. Moreover, we collected data on COPD participants from the National Health and Nutrition Examination Survey (NHANES), spanning the period from 1999 to 2018. All patients included in the study had concurrent CHD and available fasting blood glucose (FBG) measurements at the time of admission. Patients were categorized into normal blood glucose and hyperglycemia groups based on whether their FBG exceeded 7 mmol\/L. Self-administered questionnaires, clinical records, and self-reported data were the primary methods for data collection. Kaplan\u2013Meier survival analyses and Cox proportional hazard models were used to assess the risk of acute exacerbation and all-cause mortality for COPD patients with CHD during the follow-up period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among patients with both COPD and CHD, patients in the hyperglycemia group had lower smoking index, higher prevalence of diabetes, lower eosinophil percentage (Eos%), notably elevated C-reactive protein (CRP) and brain natriuretic peptide (BNP) levels, reduced albumin (ALB) levels, and higher incidence of fungal positivity than patients in the normal blood glucose group (p\u2009&lt;\u20090.05). Age (HR\u2009=\u20091.098, 95% CI\u2009=\u20091.013\u20131.191, p\u2009=\u20090.024), hyperglycemia (HR\u2009=\u20093.622, 95% CI\u2009=\u20091.08\u201312.15, p\u2009=\u20090.037), and comorbidities with obsolete pulmonary tuberculosis (HR\u2009=\u20093.185, 95% CI\u2009=\u20091.03\u20139.85, p\u2009=\u20090.044) were identified as independent predictors of mortality in multivariate analyses over the follow-up years. Hyperglycemia, age, smoking, white blood cell count (WBC), uric acid (UA), creatinine (Cr), ALB, and aspartate aminotransferase (AST) were also identified as independent predictors of mortality in multivariate analyses during the follow-up years, according to NHANES data. Kaplan\u2013Meier survival curves demonstrated that patients in the hyperglycemia group experienced significantly higher rates of exacerbations and mortality compared to those in the normal blood glucose group over a follow-up period of 5 years or more (log-rank test, p\u2009&lt;\u20090.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hyperglycemia serves as an independent risk factor for prolonged acute exacerbations and mortality in COPD patients complicated with CHD post-discharge. Proactive intervention strategies targeting hyperglycemia should be promptly instituted to mitigate the risk of future acute exacerbations and mortality in COPD patients with CHD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0335935","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T18:28:37Z","timestamp":1764959317000},"page":"e0335935","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["The impact of hyperglycemia on prognosis in chronic obstructive pulmonary disease patients with coronary heart disease: A five-year prospective study"],"prefix":"10.1371","volume":"20","author":[{"given":"Zhongshang","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenjie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7713-6913","authenticated-orcid":true,"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"1","key":"pone.0335935.ref001","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-2600(23)00461-7","article-title":"GOLD COPD report: 2024 update","volume":"12","author":"P Venkatesan","year":"2024","journal-title":"Lancet Respir Med"},{"key":"pone.0335935.ref002","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-069679","article-title":"Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019","volume":"378","author":"S Safiri","year":"2022","journal-title":"BMJ"},{"issue":"5","key":"pone.0335935.ref003","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S2213-2600(21)00511-7","article-title":"Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis","volume":"10","author":"D Adeloye","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"10131","key":"pone.0335935.ref004","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(18)30841-9","article-title":"Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study","volume":"391","author":"C Wang","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"pone.0335935.ref005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0265682","article-title":"Factors associated with coronary heart disease in COPD patients and controls","volume":"17","author":"CD Svendsen","year":"2022","journal-title":"PLoS One"},{"issue":"11","key":"pone.0335935.ref006","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/thx.2009.128082","article-title":"Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care","volume":"65","author":"JR Feary","year":"2010","journal-title":"Thorax"},{"issue":"1","key":"pone.0335935.ref007","doi-asserted-by":"crossref","first-page":"16589","DOI":"10.1038\/s41598-022-20884-3","article-title":"Secular trend and risk factors of 30-day COPD-related readmission in Beijing, China","volume":"12","author":"J Li","year":"2022","journal-title":"Sci Rep"},{"issue":"17","key":"pone.0335935.ref008","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.jacc.2018.11.063","article-title":"Association of Cardiovascular Disease With Respiratory Disease","volume":"73","author":"P Carter","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"pone.0335935.ref009","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s13104-022-06217-7","article-title":"The relationship between glycated hemoglobin A1c levels and exacerbation status in the patients with chronic obstructive pulmonary disease","volume":"15","author":"B Motamed","year":"2022","journal-title":"BMC Res Notes"},{"issue":"1","key":"pone.0335935.ref010","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s40200-021-00766-7","article-title":"Characteristics and outcomes of diabetic patients with acute exacerbation of COPD","volume":"20","author":"E Monsour","year":"2021","journal-title":"J Diabetes Metab Disord"},{"key":"pone.0335935.ref011","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.2147\/COPD.S378259","article-title":"Elevated Blood Glucose is Associated with Severe Exacerbation of Chronic Obstructive Pulmonary Disease","volume":"17","author":"G Chen","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"pone.0335935.ref012","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2147\/COPD.S122382","article-title":"Determining prognosis in acute exacerbation of COPD","volume":"12","author":"Y Flattet","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"pone.0335935.ref013","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12890-020-01371-9","article-title":"Analysis of prevalence and prognosis of type 2 diabetes mellitus in patients with acute exacerbation of COPD","volume":"21","author":"L Lin","year":"2021","journal-title":"BMC Pulm Med"},{"issue":"1","key":"pone.0335935.ref014","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12933-023-01883-8","article-title":"High triglyceride-glucose index and stress hyperglycemia ratio as predictors of adverse cardiac events in patients with coronary chronic total occlusion: a large-scale prospective cohort study","volume":"22","author":"Y Song","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"pone.0335935.ref015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12933-023-01759-x","article-title":"Association between the stress hyperglycemia ratio and severity of coronary artery disease under different glucose metabolic states","volume":"22","author":"Y Zhang","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"pone.0335935.ref016","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1164\/rccm.202009-3533SO","article-title":"Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease","volume":"203","author":"DMG Halpin","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"issue":"149","key":"pone.0335935.ref017","doi-asserted-by":"crossref","first-page":"180057","DOI":"10.1183\/16000617.0057-2018","article-title":"Cardiovascular disease and COPD: dangerous liaisons?","volume":"27","author":"KF Rabe","year":"2018","journal-title":"Eur Respir Rev"},{"issue":"3","key":"pone.0335935.ref018","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.pcd.2021.01.002","article-title":"Importance of hyperglycemia in COVID-19 intensive-care patients: Mechanism and treatment strategy","volume":"15","author":"F Mirzaei","year":"2021","journal-title":"Prim Care Diabetes"},{"issue":"8","key":"pone.0335935.ref019","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.2337\/db07-0763","article-title":"siRNA-mediated reduction of inhibitor of nuclear factor-kappaB kinase prevents tumor necrosis factor-alpha-induced insulin resistance in human skeletal muscle","volume":"57","author":"RL Austin","year":"2008","journal-title":"Diabetes"},{"issue":"5622","key":"pone.0335935.ref020","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1126\/science.1082889","article-title":"Mitochondrial dysfunction in the elderly: possible role in insulin resistance","volume":"300","author":"KF Petersen","year":"2003","journal-title":"Science"},{"issue":"1","key":"pone.0335935.ref021","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12931-020-01358-4","article-title":"Alantolactone suppresses inflammation, apoptosis and oxidative stress in cigarette smoke-induced human bronchial epithelial cells through activation of Nrf2\/HO-1 and inhibition of the NF-\u03baB pathways","volume":"21","author":"X Dang","year":"2020","journal-title":"Respir Res"},{"issue":"1","key":"pone.0335935.ref022","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jaci.2016.05.011","article-title":"Inflammatory mechanisms in patients with chronic obstructive pulmonary disease","volume":"138","author":"PJ Barnes","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"pone.0335935.ref023","doi-asserted-by":"crossref","first-page":"119090","DOI":"10.1016\/j.lfs.2021.119090","article-title":"Cigarette smoke extract induces pyroptosis in human bronchial epithelial cells through the ROS\/NLRP3\/caspase-1 pathway","volume":"269","author":"M-Y Zhang","year":"2021","journal-title":"Life Sci"},{"key":"pone.0335935.ref024","doi-asserted-by":"crossref","first-page":"101544","DOI":"10.1016\/j.redox.2020.101544","article-title":"Oxidative stress-based therapeutics in COPD","volume":"33","author":"PJ Barnes","year":"2020","journal-title":"Redox Biol"},{"key":"pone.0335935.ref025","doi-asserted-by":"crossref","first-page":"1073878","DOI":"10.3389\/fendo.2023.1073878","article-title":"Diabetic endothelial microangiopathy and pulmonary dysfunction","volume":"14","author":"L Zhang","year":"2023","journal-title":"Front Endocrinol"},{"key":"pone.0335935.ref026","doi-asserted-by":"crossref","first-page":"20406223231171556","DOI":"10.1177\/20406223231171556","article-title":"Cardiovascular diseases or type 2 diabetes mellitus and chronic airway diseases: mutual pharmacological interferences","volume":"14","author":"M Cazzola","year":"2023","journal-title":"Ther Adv Chronic Dis"},{"issue":"10","key":"pone.0335935.ref027","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"N Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"pone.0335935.ref028","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/CIRCULATIONAHA.117.028136","article-title":"Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors","volume":"136","author":"MA Nauck","year":"2017","journal-title":"Circulation"},{"key":"pone.0335935.ref029","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.2147\/COPD.S257679","article-title":"Association Between Systemic and Pulmonary Vascular Dysfunction in COPD","volume":"15","author":"L Piccari","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"pone.0335935.ref030","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.amjcard.2024.06.005","article-title":"Atherosclerotic Coronary Plaque Features in Patients With Chronic Obstructive Pulmonary Disease and Acute Coronary Syndrome","volume":"224","author":"M Russo","year":"2024","journal-title":"Am J Cardiol"},{"issue":"8","key":"pone.0335935.ref031","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1164\/rccm.202006-2467OC","article-title":"Hypoxia Increases the Potential for Neutrophil-mediated Endothelial Damage in Chronic Obstructive Pulmonary Disease","volume":"205","author":"KM Lodge","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"pone.0335935.ref032","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/17476348.2021.1919089","article-title":"Vascular endothelial damage in COPD: current functional assessment methods and future perspectives","volume":"15","author":"MP Theodorakopoulou","year":"2021","journal-title":"Expert Rev Respir Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0335935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T18:28:43Z","timestamp":1764959323000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0335935"}},"subtitle":[],"editor":[{"given":"Hidetaka","family":"Hamasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0335935","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]}}}